Results 161 to 170 of about 441,361 (298)

Under-diagnosis of Takotsubo Cardiomyopathy Increases Risk of Adverse Events: A Case Study [PDF]

, 2019
Harvinder Singh Power
openalex   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

LV Noncompaction Cardiomyopathy or Just a Lot of Trabeculations?

, 2016
Nay Aung, Filip Zemrak, Saidi Mohiddin, Steffen E. Petersen   +3 more
openalex   +2 more sources

Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory [PDF]

, 2022
Tonje Talsnes Stava, Trond P. Leren, Martin P. Bogsrud   +2 more
openalex   +1 more source

Takotsubo cardiomyopathy with rapid left ventricular recovery unmasking asymptomatic but significant coronary artery disease: a case report. [PDF]

J Med Case Rep
Elzain H, Karar MNM, Mostafa MA, Redha JH, Babiker AB, Alasousi N.   +5 more
europepmc   +1 more source

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Circulation Research, 2017
A. Marian, E. Braunwald
semanticscholar   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Editorial: Hypertrophic Cardiomyopathy and Precision Medicine in Cardiovascular Disease. [PDF]

Med Sci Monit
Parums DV.
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Periprocedural Outcomes of VT Ablation in Ischemic Compared to Non-Ischemic Dilated Cardiomyopathy. [PDF]

Ann Noninvasive Electrocardiol
Duhan S, Ali S, Alsaeed T, Kumar M, Keisham B, S Mehta S, Adoni NA, Mongwa M, Rhee BJ, Garg A.   +9 more
europepmc   +1 more source